Gabapentin Tablet
Product Images NDC 76282-706

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76282-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clcr (Equation)

An illustration depicting the formula for calculating creatinine clearance (CLCr). The formula is shown as: [(140 minus age in years) times weight in kilograms] divided by (72 times serum creatinine in mg/dL), multiplied by 0.85 for female patients. This formula is commonly used to estimate kidney function.*

FDA Label Image

Struc (Struct)

Chemical structure diagram of gabapentin, showing a cyclohexane ring with attached side chains including CH2NH2 and CH2CO2H groups. The structure represents the active ingredient gabapentin used in the GABAPENTIN oral tablet product by Exelan Pharmaceuticals, Inc.*

FDA Label Image

Figure-1 (Figure1)

A line graph titled 'Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1' showing the mean pain scores over 8 weeks for two groups: placebo and gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis represents mean pain scores from 0 to 10. Gabapentin group's pain scores decrease steadily over time, while placebo group's scores remain relatively constant. The graph also indicates a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure-2 (Figure2)

A line chart titled 'Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2' depicting mean pain scores from baseline to week 7. It compares placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups over a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, and the x-axis shows weeks 0 to 7.*

FDA Label Image

Figure-3 (Figure3)

A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' depicting results from two studies. The chart compares placebo (PBO) and gabapentin (GBP) at various dosages (1800 mg, 2400 mg, 3600 mg) showing the percentage of patients achieving significant pain reduction.*

FDA Label Image

Figure-4 (Figure4)

A scatter plot showing the responder rate difference (%) from placebo in patients receiving Gabapentin by daily dose in mg from three adjunctive therapy studies in patients aged 12 years and older with partial seizures. The x-axis shows daily dose (600, 900, 1200, 1800 mg), and the y-axis shows difference in response rate. Different squares represent Study a, Study b, and Study c data points.*

FDA Label Image

600 mg-90s (600 90 Tabs)

Packaging label for Gabapentin Tablets, USP 600 mg by Exelan Pharmaceuticals, Inc. The label shows NDC 76282-706-90 and indicates a package size of 90 tablets. Storage instructions specify controlled room temperature with excursions permitted between 59° to 86°F. The label includes dispensing guidance and manufacturer details for Ascent Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc.*

FDA Label Image

600 mg-500s (600 500 Tabs)

GABAPENTIN 600 mg oral tablets label from Exelan Pharmaceuticals, Inc. The label indicates the product is for prescription use only, with a package size of 500 tablets. It includes storage instructions and notes that each tablet contains 600 mg of gabapentin. Manufactured by Ascent Pharmaceuticals, Inc. and labeled for Exelan Pharmaceuticals, Inc.*

FDA Label Image

800 mg-90s (800 90 Tabs)

Label for Gabapentin Tablets USP 800 mg from Exelan Pharmaceuticals, Inc. The label includes storage instructions, dosage and use notes, and specifies the product contains 90 tablets. It states the product is Rx only and includes the NDC 76282-707-90. Manufacturer and distributor information is also printed.*

FDA Label Image

800 mg-500s (800 500 Tabs)

Label for Gabapentin Tablets, USP 800 mg oral tablets, packaged by Exelan Pharmaceuticals, Inc. The label indicates a package size of 500 tablets and includes storage instructions, reference to the medication guide, and manufacturing details identifying Ascent Pharmaceuticals, Inc. as the manufacturer and Exelan Pharmaceuticals, Inc. as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.